Penumbra, Inc. Reports Second Quarter 2026 Financial Results
Go back to Penumbra, Inc. Reports Second Quarter 2026 Financial Results| Boston Scientific (NYSE: BSX) | Delayed: 50.37 +1.00 (2.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.37 | 52 Week High | $24.79 | |||
| Open | $49.22 | 52 Week Low | $15.67 | |||
| Day High | $50.90 | P/E | N/A | |||
| Day Low | $49.01 | EPS | $-0.09 | |||
| Volume | 35,991,883 | |||||
| (NYSE: PEN) | Delayed: 325.18 +1.42 (0.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $323.76 | 52 Week High | $79.49 | |||
| Open | $323.87 | 52 Week Low | $40.23 | |||
| Day High | $325.66 | P/E | N/A | |||
| Day Low | $323.87 | EPS | $0.00 | |||
| Volume | 167,124 | |||||
